Nadir CA-125 serum levels during neoadjuvant chemotherapy and no residual tumor at interval debulking surgery predict prognosis in advanced stage ovarian cancer

BACKGROUND: Recent phase III randomized trials have suggested that neoadjuvant chemotherapy followed by interval debulking surgery (NACT-IDS) is a treatment option for patients with advanced epithelial ovarian cancer. This study aimed to use CA-125 and computed tomography (CT) scanning to generate a...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :World J Surg Oncol
Главные авторы: Nakamura, Kazuto, Kitahara, Yoshikazu, Nishimura, Toshio, Yamashita, Soichi, Kigure, Keiko, Ito, Ikuro, Kanuma, Tatsuya
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2020
Предметы:
Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7427056/
https://ncbi.nlm.nih.gov/pubmed/32791996
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12957-020-01978-6
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы